ADC Therapeutics SA revenue breakdown overview

ADC Therapeutics SA revenue for the last year amounted to 69.56 M USD, the most of which — 69.56 M USD — came from its highest performing source at the moment, Antibody Drug Conjugates, the year earlier bringing 209.91 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought ADC Therapeutics SA 69.06 M USD.